BDTX-189

• Description:

  BDTX-189 is a potent and selective inhibitor of allosteric EGFR and HER2 oncogenic mutations (KDs of 0.2, 0.76, 13 and 1.2 nM for EGFR, HER2, BLK and RIPK2, reapectively) . BDTX-189 exhibits anticancer activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  561.03

• Molecular Formula:

  C29H29ClN6O4

• Notes:

  Research use only, not for human use.

• Receptor:

  BLK|EGFR|HER2|RIPK2

• CAS Number:

  2414572-47-5